Identification of unresponsive kidney-transplant recipients
No abstract listed.
IMMUNOLOGIC STUDIES IN HUMAN ORGAN TRANSPLANTATION. I. OBSERVATION AND CHARACTERIZATION OF SUPPRESSED CUTANEOUS REACTIVITY IN UREMIA
The humoral immune response against an HLA class I allodeterminant correlates with the HLA-DR phenotype of the responder
Relationship of blood transfusions to appearance of mixed leukocyte culture blocking factor activity in plasma of uraemic patients and renal allograft recipients
Long-term outcome after anesthesia and surgery: remarks on the biology of a newly emerging principle in perioperative care
Immunologic effects of blood transfusion upon renal transplantation, tumor operations, and bacterial infections
Extending the horizon for cell-based immunotherapy by understanding the mechanisms of action of photopheresis
Interaction of splenectomy and perioperative blood transfusions on prognosis of patients with proximal gastric and gastroesophageal junction cancer
Allogenic & Autologous Therapies
Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.